The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond
Open accessAbstract
Working at the Pasteur Institute in Paris in 1929, Michel Macheboeuf reported the fi rst detailed isolation of a lipidrich " ␣ -globulin" from horse serum, a fraction that would later become known as high density lipoprotein (HDL) ( 1 ).Although relatively rapid progress was made at characterizing the lipid composition of this fraction -phospholipids (PL, ف 25%), cholesterol ( ف 4%), triglycerides (TG, ف 3%) and cholesteryl esters (CE, ف 12%) -it took nearly 40 years to begin to sort out the complexities of the protein component.Part of the delay may have resulted from the widespread believe that "apo-HDL" was likely single protein entity, much like low-density lipoprotein (LDL), which was dominated by a single polypeptide later identifi ed as apolipoprotein (apo)B.Using amino acid analyses, early electrophoresis methods, and a variety chromatographic techniques, the fi rst HDL protein moiety was identifi ed in the late 1960s.Variously referred to as ␣ -protein, "R-Thr" peptide ( 2 ), fraction III ( 3 ), and fraction II peptide ( 4 ), it later became known as apoA-I ( 5 ).Working in parallel, these laboratories also fi rst recognized the possibility for heterogeneity within the HDL protein complement.This led to the identifi cation of a second protein later known as apoA-II ( 5 ).The signifi cance of this observation was not lost on these early pioneers.For example, the Shores Abstract Recent applications of mass spectrometry technology have dramatically increased our understanding of the proteomic diversity of high density lipoproteins (HDL).Depending on the method of HDL isolation, upwards of 85 proteins have been identifi ed, and the list continues to grow.In addition to proteins consistent with traditionally accepted roles in lipid transport, HDL carries surprising constituents, such as members of the complement pathway, protease inhibitors involved in hemostasis, acute-phase response proteins, immune function mediators, and even metal-binding proteins.This compositional diversity fi ts well with hundreds of studies demonstrating a wide functional pleiotrophy , including roles in lipid transport, oxidation, infl ammation, hemostasis, and immunity.This review summarizes the progression of our understanding of HDL proteomic complexity and points out key experimental observations that reinforce the functional diversity of HDL.The possibility of specifi c HDL subspecies with distinct functions, the evidence supporting this concept, and some of the best examples of experimentally defi ned HDL subspecies are also discussed.Finally, key challenges facing the fi eld are highlighted, particularly the need to identify and defi ne the function of HDL subspecies to better inform attempts to pharmacologically manipulate HDL for the benefi t of cardiovascular disease and possibly other maladies.-Shah, A. S., L.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Electrospray Ionization for Mass Spectrometry of Large Biomolecules
Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., & Whitehouse, C. M. (1989) · Science · doi:10.1126/science.2675315 · Cited by 7,634
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911
Effects of dalcetrapib in patients with a recent acute coronary syndrome
Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., Chaitman, B. R., Holme, I. M., Kallend, D., Leiter, L. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206797 · Cited by 2,022
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers.
Hillenkamp, F., Karas, M., Beavis, R. C., & Chait, B. T. (1991) · Analytical Chemistry · doi:10.1021/ac00024a716 · Cited by 1,930
Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & La Du, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1649 · Cited by 1,168
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
Mackness, M. I., Arrol, S., & Durrington, P. N. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80962-3 · Cited by 977
Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci26206 · Cited by 942 · cited 16×
“were the first to compare HDL proteomic profiles between normolipidemic subjects and patients with documented coronary artery disease (CAD) (23;75;76).”
InfluentialLipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
Hailman, E., Lichenstein, H. S., Wurfel, M. M., Miller, D. S., Johnson, D. A., Kelley, M., Busse, L. A., Zukowski, M. M., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.269 · Cited by 743
Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 668
Ansell, B. J., Navab, M., Hama, S., Kamranpour, N., Fonarow, G., Hough, G., Rahmani, S., Mottahedeh, R., Dave, R., Reddy, S. T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103624.14436.4b · Cited by 590
Apolipoprotein L-I is the trypanosome lytic factor of human serum
Vanhamme, L., Paturiaux-Hanocq, F., Poelvoorde, P., Nolan, D. P., Lins, L., Van Den Abbeele, J., Pays, A., Tebabi, P., Van Xong, H., Jacquet, A., et al. (2003) · Nature · doi:10.1038/nature01461 · Cited by 500
Aviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., Erogul, J., Hsu, C., Dunlop, C., & La Du, B. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.10.1617 · Cited by 458
HDL, its enzymes and its potential to influence lipid peroxidation
Mackness, M. I., & Durrington, P. N. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05524-m · Cited by 418
Davidson, W. S., Silva, R. A. G. D., Chantepie, S., Lagor, W. R., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186031 · Cited by 415
Self-citationStafforini, D. M., McIntyre, T. M., Carter, M. E., & Prescott, S. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61335-3 · Cited by 398
High density lipoproteins and coronary heart disease
Barter, P. J., & Rye, K.-A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05675-0 · Cited by 377 · cited 1×
“expression of cell adhesion molecules on endothelial cells which sequester circulating monocytes during injury (39).”
Transthyretin (Prealbumin) in Health and Disease: Nutritional Implications
Ingenbleek, Y., & Young, V (1994) · Annual Review of Nutrition · doi:10.1146/annurev.nu.14.070194.002431 · Cited by 375
BLATTER, M., JAMES, R. W., MESSMER, S., BARJA, F., & POMETTA, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17620.x · Cited by 347
The roles of different pathways in the release of cholesterol from macrophages
Adorni, M. P., Zimetti, F., Billheimer, J. T., Wang, N., Rader, D. J., Phillips, M. C., & Rothblat, G. H. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700274-jlr200 · Cited by 333
The metabolism and anti-atherogenic properties of HDL
Rye, K.-A., Bursill, C. A., Lambert, G., Tabet, F., & Barter, P. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800034-jlr200 · Cited by 331
Scanu, A., Toth, J., Edelstein, C., Koga, S., & Stiller, E. (1969) · Biochemistry · doi:10.1021/bi00836a027 · Cited by 325
Isolation and characterization of polypeptides of human serum lipoproteins
Shore, B., & Shore, V. G. (1969) · Biochemistry · doi:10.1021/bi00839a043 · Cited by 269
Uremia Alters HDL Composition and Function
Holzer, M., Birner-Gruenberger, R., Stojakovic, T., El-Gamal, D., Binder, V., Wadsack, C., Heinemann, A., & Marsche, G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111144 · Cited by 268
Role of Serum Amyloid A During Metabolism of Acute-Phase HDL by Macrophages
Artl, A., Marsche, G., Lestavel, S., Sattler, W., & Malle, E. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.763 · Cited by 254
Gordon, S. M., Deng, J., Lu, L. J., & Davidson, W. S. (2010) · Journal of Proteome Research · doi:10.1021/pr100520x · Cited by 241
Self-citationKarlsson, H., Leanderson, P., Tagesson, C., & Lindahl, M. (2005) · PROTEOMICS · doi:10.1002/pmic.200401010 · Cited by 241
Chait, A., Han, C. Y., Oram, J. F., & Heinecke, J. W. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r400017-jlr200 · Cited by 233
Griffin, J. H., Kojima, K., Banka, C. L., Curtiss, L. K., & Fernández, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5006 · Cited by 232
Gu, X., Trigatti, B., Xu, S., Acton, S., Babitt, J., & Krieger, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26338 · Cited by 220
Human Plasma Platelet-Activating Factor Acetyl hydrolase
Stafforini, D. M., & Tjoelker, L. W. (2003) · Lipase and Phospholipase Protocols · doi:10.1385/1-59259-581-2:49 · Cited by 216
Mcadam, K. P. W. J., & Sipe, J. D. (1976) · The Journal of Experimental Medicine · doi:10.1084/jem.144.4.1121 · Cited by 215
Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins
Jonas, A. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90062-m · Cited by 214
Parker, T. S., Levine, D. M., Chang, J. C., Laxer, J., Coffin, C. C., & Rubin, A. L. (1995) · Infection and Immunity · doi:10.1128/iai.63.1.253-258.1995 · Cited by 211
Identification of the trypanocidal factor in normal human serum: high density lipoprotein.
Rifkin, M. R. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3450 · Cited by 211
Serum Amyloid A in Uremic HDL Promotes Inflammation
Weichhart, T., Kopecky, C., Kubicek, M., Haidinger, M., Döller, D., Katholnig, K., Suarna, C., Eller, P., Tölle, M., Gerner, C., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011070668 · Cited by 201
The HDL proteome in acute coronary syndromes shifts to an inflammatory profile
Alwaili, K., Bailey, D., Awan, Z., Bailey, S. D., Ruel, I., Hafiane, A., Krimbou, L., Laboissiere, S., & Genest, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.07.013 · Cited by 201
Calkin, A. C., Drew, B. G., Ono, A., Duffy, S. J., Gordon, M. V., Schoenwaelder, S. M., Sviridov, D., Cooper, M. E., Kingwell, B. A., & Jackson, S. P. (2009) · Circulation · doi:10.1161/circulationaha.109.870709 · Cited by 200
Hutt, C. J. (1973) · Medical Entomology and Zoology · Cited by 195
Tall, A. R., Krumholz, S., Olivecrona, T., & Deckelbaum, R. J. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34314-5 · Cited by 193
Lysis of Trypanosoma brucei by a Toxic Subspecies of Human High Density Lipoprotein
Hajduk, S. L., Moore, D. R., Vasudevacharya, J., Siqueira, H., Torri, A. F., Tytler, E. M., & Esko, J. D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83720-6 · Cited by 177
Proteomic analysis of high‐density lipoprotein
Rezaee, F., Casetta, B., Levels, J. H. M., Speijer, D., & Meijers, J. C. M. (2006) · PROTEOMICS · doi:10.1002/pmic.200500191 · Cited by 174
Moore, R. E., Navab, M., Millar, J. S., Zimetti, F., Hama, S., Rothblat, G. H., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000185320.82962.f7 · Cited by 173
Psoriasis alters HDL composition and cholesterol efflux capacity
Holzer, M., Wolf, P., Curcic, S., Birner-Gruenberger, R., Weger, W., Inzinger, M., El-Gamal, D., Wadsack, C., Heinemann, A., & Marsche, G. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m027367 · Cited by 170
Cai, L., Ji, A., de Beer, F. C., Tannock, L. R., & van der Westhuyzen, D. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci31539 · Cited by 167
Kinnunen, P. K., Jackson, R. L., Smith, L. C., Gotto, A. M., & Sparrow, J. T. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4848 · Cited by 167
Watanabe, J., Charles‐Schoeman, C., Miao, Y., Elashoff, D., Lee, Y. Y., Katselis, G., Lee, T. D., & Reddy, S. T. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34363 · Cited by 161
Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy
Cruz, D., Watson, A. D., Miller, C. S., Montoya, D., Ochoa, M.-T., Sieling, P. A., Gutierrez, M. A., Navab, M., Reddy, S. T., Witztum, J. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34189 · Cited by 161
The Heparin/Heparan Sulfate-binding Site on Apo-serum Amyloid A
Ancsin, J. B., & Kisilevsky, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7172 · Cited by 158
Shiflett, A. M., Bishop, J. R., Pahwa, A. K., & Hajduk, S. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503510200 · Cited by 148
Lipoproteins inhibit macrophage activation by lipoteichoic acid
Grünfeld, C., Marshall, M. K., Shigenaga, J. K., Moser, A. H., Tobias, P. S., & Feingold, K. R. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33363-0 · Cited by 147
Heterogeneity of human serum amyloid A proteins.
Bausserman, L., Herbert, P. N., & Mcadam, K. P. W. J. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.3.641 · Cited by 146
Jensen, M. K., Rimm, E. B., Furtado, J. D., & Sacks, F. M. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.111.000232 · Cited by 142
Mass spectrometry technologies for proteomics
Cañas, B., López‐Ferrer, D., Ramos-Fernández, A., Camafeita, E., & Calvo, E. (2006) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/eli002 · Cited by 141
Hoofnagle, A. N., Becker, J. O., Oda, M. N., Cavigiolio, G., Mayer, P., & Vaisar, T. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.173856 · Cited by 140
Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity
Vergeer, M., Bots, M. L., van Leuven, S. I., Basart, D. C. G., Sijbrands, E. J. G., Evans, G. W., Grobbee, D. E., Visseren, F. L. J., Stalenhoef, A. F. H., Stroes, E. S. G., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.772665 · Cited by 133
Combined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome
Green, P. S., Vaisar, T., Pennathur, S., Kulstad, J. J., Moore, A. B., Marcovina, S. M., Brunzell, J. D., Knopp, R. H., Zhao, X.-Q., & Heinecke, J. W. (2008) · Circulation · doi:10.1161/circulationaha.108.770669 · Cited by 131
Mahley, R. W., & Innerarity, T. L. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40346-2 · Cited by 127
Annema, W., Nijstad, N., Tölle, M., de Boer, J. F., Buijs, R. V. C., Heeringa, P., van der Giet, M., & Tietge, U. J. F. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m000323 · Cited by 127
High‐density lipoproteins, platelets and the pathogenesis of atherosclerosis
Nofer, J., Brodde, M. F., & Kehrel, B. E. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05377.x · Cited by 125
Villarroel‐Espíndola, F., Bastías, A., Casado, A., Amthauer, R., & Concha, M. I. (2006) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2006.10.008 · Cited by 115
Concha, M. I., Smith, V. J., Castro, K., Bastías, A., Romero, A., & Amthauer, R. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04228.x · Cited by 113
High-density lipoprotein subpopulations in pathologic conditions
Asztalos, B. F., & Schaefer, E. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03383-0 · Cited by 106
James, R. W., Hochstrasser, D. F., Tissot, J., Funk, M., Appel, R. D., Barja, F., Pellegrini, C., Muller, A. F., & Pometta, D. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38408-x · Cited by 106
Krauss, R. M., Wojnooski, K., Orr, J., Geaney, J. C., Pinto, C. A., Liu, Y., Wagner, J. A., Luk, J. A. M., Johnson‐Levonas, A. O., Anderson, M. S., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m018010 · Cited by 99
Li, Y., Dong, J., & Wu, M.-P. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.047 · Cited by 96
Olofsson, S. O., McConathy, W. J., & Alaupovic, P. (1978) · Biochemistry · doi:10.1021/bi00599a014 · Cited by 95
Role of Apolipoprotein A-I in Protecting against Endotoxin Toxicity
Ma, J., Liao, X., Lou, B., & Wu, M.-P. (2004) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/36.6.419 · Cited by 94
High-density lipoprotein and the acute phase response
Jahangiri, A. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328337278b · Cited by 93
Wang, X., Driscoll, D. M., & Morton, R. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1814 · Cited by 90
Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo
Puranik, R., Bao, S., Nobécourt, E., Nicholls, S. J., Dusting, G. J., Barter, P. J., Celermajer, D. S., & Rye, K.-A. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.008 · Cited by 90
Heterogeneity in protein subunits of human serum high-density lipoproteins
SHORE, B., & Shore, V. G. (1968) · Biochemistry · doi:10.1021/bi00848a011 · Cited by 90
Thrombocytopenia and Platelet Abnormalities in High-Density Lipoprotein Receptor–Deficient Mice
Dole, V. S., Matuskova, J., Vasile, E., Yesilaltay, A., Bergmeier, W., Bernimoulin, M. P., Wagner, D. D., & Krieger, M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.162347 · Cited by 89
The role of HDL in innate immunity
Feingold, K. R., & Grünfeld, C. (2010) · Journal of Lipid Research · doi:10.1194/jlr.e012138 · Cited by 87
Hoofnagle, A. N., Wu, M., Gosmanova, A. K., Becker, J. O., Wijsman, E. M., Brunzell, J. D., Kahn, S. E., Knopp, R. H., Lyons, T. J., & Heinecke, J. W. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.212894 · Cited by 87
Heller, M., Stalder, D., Schlappritzi, E., Hayn, G., Matter, U., & Haeberli, A. (2005) · PROTEOMICS · doi:10.1002/pmic.200401233 · Cited by 83
HDL in humans with cardiovascular disease exhibits a proteomic signature
Vaisar, T., Mayer, P. S., Nilsson, E. J., Zhao, X. Q., Knopp, R. H., & Prazen, B. J. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.03.023 · Cited by 80
ROSENFELD, S. I., Packman, C. H., & Leddy, J. P. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110833 · Cited by 73
Gordon, S. M., Deng, J., Tomann, A. B., SHAH, A. S., Lu, L. J., & Davidson, W. S. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.028134 · Cited by 72
Self-citationMangé, A., Goux, A., Badiou, S., Patrier, L., Canaud, B., Maudelondé, T., Cristol, J., & Solassol, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034107 · Cited by 71
Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency
Santos, R. D., Schaefer, E. J., Asztalos, B. F., Polisecki, E. Y., Wang, J., Hegele, R. A., Martinez, L. R. C., Miname, M. H., Rochitte, C. E., da Luz, P. L., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700362-jlr200 · Cited by 70
Kontush, A., & Chapman, M. J. (2011) · Wiley eBooks · doi:10.1002/9781118158678 · Cited by 68
A new method for isolating the nonidentical protein subunits of human plasma α-lipoprotein
Rudman, D. R., Garcia, L. A., & Howard, C. H. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106245 · Cited by 66
Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum
Vanhollebeke, B., Nielsen, M. J., Watanabe, Y., Truc, P., Vanhamme, L., Nakajima, K., Moestrup, S. K., & Pays, É. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609902104 · Cited by 65
Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation
Hine, D. G., Mackness, B., & Mackness, M. (2011) · IUBMB Life · doi:10.1002/iub.588 · Cited by 64
Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid
Jiao, Y.-L., & Wu, M.-P. (2008) · Cytokine · doi:10.1016/j.cyto.2008.04.002 · Cited by 62
Diverse range of small peptides associated with high-density lipoprotein
Hortin, G. L., Shen, R., Martin, B. M., & Remaley, A. T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.098 · Cited by 61
Courtney, H. S., Zhang, Y., Frank, M. W., & Rock, C. O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512538200 · Cited by 56
Jahangiri, A., Rader, D. J., Marchadier, D. H. L., Curtiss, L. K., Bonnet, D. J., & Rye, K.-A. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400212-jlr200 · Cited by 54
Cheung, M. C., Vaisar, T., Han, X., Heinecke, J. W., & Albers, J. J. (2010) · Biochemistry · doi:10.1021/bi100359f · Cited by 53
Apolipoprotein A-I from striped bass (Morone saxatilis) demonstrates antibacterial activity in vitro
Johnston, L. D., Brown, G. D., Gauthier, D. T., Reece, K. S., Kator, H. I., & Veld, P. V. (2008) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2008.06.011 · Cited by 49
Hyperlipidemia as an Instigator of Inflammation: Inaugurating New Approaches to Vascular Prevention
Ridker, P. M. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.000497 · Cited by 49
Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production
Aviram, M., Sirtori, C. R., Colli, S., MADERNA, P., Morazzoni, G., & Tremoli, E. (1985) · Biochemical Medicine · doi:10.1016/0006-2944(85)90059-6 · Cited by 37
Rubinow, K. B., Vaisar, T., Tang, C., Matsumoto, A. M., Heinecke, J. W., & Page, S. T. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p026005 · Cited by 37
Loued, S., Isabelle, M., Berrougui, H., & Khalil, A. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.10.018 · Cited by 36
Targeting High Density Lipoproteins in the Prevention of Cardiovascular Disease?
Larach, D. B., deGoma, E. M., & Rader, D. J. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0317-3 · Cited by 33
Mehta, J., & Chen, L. Y. (1996) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(96)90097-9 · Cited by 31
Rubinow, K. B., Tang, C., Hoofnagle, A. N., Snyder, C. N., Amory, J. K., Heinecke, J. W., & Page, S. T. (2012) · Steroids · doi:10.1016/j.steroids.2012.01.002 · Cited by 21
Boyle, K., Phillips, M. C., & Lund‐Katz, S. (1999) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00009-6 · Cited by 19
Distribution of lipids and apolipoproteins in human plasma by vertical spin ultracentrifugation
Campos, E. M., & McConathy, W. J. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90022-6 · Cited by 15
Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans
Oslakovic, C., Norstrøm, E. A., & Dahlbäck, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42260 · Cited by 15
Figueiredo, P. M., Catani, C. F., & Yano, T. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00125-1 · Cited by 13
Cited by
Ouimet, M., Barrett, T. J., & Fisher, E. A. (2019) · Circulation Research · doi:10.1161/circresaha.119.312617 · Cited by 761
What Are We Looking At? Extracellular Vesicles, Lipoproteins, or Both?
Simonsen, J. B. (2017) · Circulation Research · doi:10.1161/circresaha.117.311767 · Cited by 350
High-density lipoproteins: A consensus statement from the National Lipid Association
Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336
Self-citationHigh-Density Lipoproteins: Nature’s Multifunctional Nanoparticles
Kuai, R., Li, D., Chen, Y. E., Moon, J. J., & Schwendeman, A. (2016) · ACS Nano · doi:10.1021/acsnano.5b07522 · Cited by 338
Quantitative variability of 342 plasma proteins in a human twin population
Liu, Y., Buil, A., Collins, B. C., Gillet, L. C., Blum, L. C., Cheng, L., Vitek, O., Mouritsen, J., Lachance, G., Spector, T. D., et al. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145728 · Cited by 328
Metadata
- Authors
- Shah, A. S., Tan, L., Long, J. L., & Davidson, W. S.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 54
- Issue
- 10
- Pages
- 2575-2585
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2054786421
- Cited by
- 351
- References
- 105
- FWCI
- 35.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.